Potential immunologic and prognostic roles of CHRNA6 in SCLC and pan-cancer
Our findings indicate that the CHRNA6 may act as a predictive indicator for SCLC patients receiving immunotherapy. The study also uncovers the aberrant expression of CHRNA6 in a range of human cancers and its potential roles in immunology and prognosis, offering novel perspectives for tailored cancer therapies.
Authors
- Xiaoli Zhu (ORCID: https://orcid.org/0000-0003-2910-9328)
- Cong Wang (ORCID: https://orcid.org/0000-0002-5601-2145)
- Wucui Huang (ORCID: https://orcid.org/0000-0002-6221-2426)
- Lang Yang (ORCID: https://orcid.org/0000-0002-6699-4699)
- Qingqing Zhao (ORCID: https://orcid.org/0000-0002-2932-9702)
- Zhongquan Song
Institutions
- Xuzhou Medical College (CN)
- Zhongda Hospital Southeast University (CN)
- Southeast University (CN)
Publication Details
- Journal
- Heliyon
- Published
- 2024-09-26
- DOI
- https://doi.org/10.1016/j.heliyon.2024.e38572
- Citations
- 1
- Primary Topic
- Lung Cancer Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.28